$2.45
0.07[2.94%]
At close: Apr 24
$2.45
0[0.00%]
PreMarket: 5:55PM EDT
Stereotaxis
(AMEX:STXS)Latest News for Stereotaxis Stock (AMEX:STXS)
Stereotaxis Stock (AMEX: STXS)
Categories: All
Tuesday, March 05, 2024
Monday, March 04, 2024
- Stereotaxis Anticipates Double Digit Revenue Growth For Full Year 2024; Sees Q1 Revenue Of ~$7M (Est $6.70M)Benzinga Newsdesk - Mar 4, 2024, 5:22PM
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Mar 4, 2024, 4:32PM
- Recap: Stereotaxis Q4 EarningsBenzinga Insights - Mar 4, 2024, 4:10PM
- Stereotaxis Says Regulatory Submissions Were Made Recently In Both Europe And US For MAGiC CatheterBenzinga Newsdesk - Mar 4, 2024, 4:08PM
- Stereotaxis Q4 2023 GAAP EPS $(0.070), Inline, Sales $4.565M Miss $7.700M EstimateBenzinga Newsdesk - Mar 4, 2024, 4:07PM
- Earnings Scheduled For March 4, 2024Benzinga Insights - Mar 4, 2024, 4:53AM
Friday, March 01, 2024
Friday, January 12, 2024
Wednesday, January 10, 2024
Monday, January 08, 2024
Wednesday, December 06, 2023
Tuesday, November 28, 2023
Thursday, November 09, 2023
Tuesday, October 31, 2023
Monday, September 18, 2023
Wednesday, September 06, 2023
Tuesday, August 29, 2023
Thursday, August 10, 2023
Tuesday, July 18, 2023
Thursday, July 06, 2023
Friday, June 16, 2023
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Jun 16, 2023, 1:32PM
- Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jun 16, 2023, 1:08PM
- Stereotaxis shares are trading lower. The company on Thursday announced it intends to initiate a trial to support CE Mark submission for its MAGiC catheter and said the European Notified Body has requested clinical data to support the submission.Benzinga Newsdesk - Jun 16, 2023, 10:43AM
- US Stocks Mixed; Dow Gains 50 PointsLisa Levin - Jun 16, 2023, 9:49AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Jun 16, 2023, 9:08AM
Thursday, June 15, 2023
Friday, May 19, 2023
- Crude Oil Down 1%; Foot Locker Earnings Miss ExpectationsLisa Levin - May 19, 2023, 2:30PM
- Watching Stereotaxis; Hearing B. Riley Sets Buy Rating, $5.50 Price TargetBenzinga Newsdesk - May 19, 2023, 1:36PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - May 19, 2023, 1:31PM
- Stereotaxis, Abbott Ink Pact To Combine Mapping & Robotic Tech: FDA Approves Abbott's Next-Gen Abalation CatheterVandana Singh - May 19, 2023, 1:23PM
- Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - May 19, 2023, 1:21PM
- US Stocks Turn Lower; Dow Dips Over 100 PointsLisa Levin - May 19, 2023, 12:04PM
- Sterotaxis shares are trading higher after the company announced a global collaboration with Abbott to integrate Abbott's EnSite X EP System with the company's Robotic Magnetic Navigation systems.Benzinga Newsdesk - May 19, 2023, 9:59AM
- Stereotaxis And Abbott Announce Global Collaboration Combining Leading Mapping And Robotic Technologies To Improve Treatment Of Abnormal Heart RhythmsHappy Mohamed - May 19, 2023, 8:40AM
Tuesday, May 09, 2023
Monday, May 08, 2023
Monday, March 06, 2023
- Piper Sandler Maintains Overweight on Stereotaxis, Lowers Price Target to $5Benzinga Newsdesk - Mar 6, 2023, 10:13AM
- Lake Street Maintains Buy on Stereotaxis, Lowers Price Target to $4Benzinga Newsdesk - Mar 6, 2023, 8:58AM
- B. Riley Securities Maintains Buy on Stereotaxis, Lowers Price Target to $5.5Benzinga Newsdesk - Mar 6, 2023, 8:46AM